Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Identifying the correct uveitis type can help reveal underlying systemic infections, neoplastic conditions, and other ...

Lantheus ( ($LNTH) ) has issued an update. On July 21, 2025, Lantheus completed its acquisition of Life Molecular Imaging Limited, enhancing its ...

In a scientific first, researchers from Vanderbilt University and the University of California, San Diego, have generated a high-resolution metabolic "map" of how cells orchestrate glucose processing, ...

One of ANSTO's advanced imaging instruments Dingo now delivers a rare fusion of simulation and radiobiology, becoming a ...

In a new study, researchers show, for the first time, that photoacoustic microscopy can image stents through skin, ...

A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

Modern radiotherapy faces two critical challenges: overcoming biological heterogeneity and enhancing physical precision beyond anatomical constraints.

Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has ...